Company Profile
Company Overview
Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company’s initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.
The ATI Neurostimulation System was voted #2 among the Cleveland Clinic’s top 10 medical innovations for 2013, and Autonomic Technologies was named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world.
ATI, a Cleveland Clinic Innovations spinoff, is located in the San Francisco Bay Area and is backed by blue chip investors Edmond de Rothschild Investment Partners, Forbion Capital Partners, HBM Healthcare Investments Ltd , Kleiner Perkins Caufield and Byers, InterWest Partners, Versant Ventures, Novartis Ventures, Aberdare Ventures & Cleveland Clinic.
Benefits
At ATI, we are committed to creating a collaborative, nimble and exciting work environment. Our culture is based on respect, integrity, collaboration, creativity and accountability and we look for dedicated people to join our team who are driven by the pursuit of excellence and who want to make a significant difference in the lives of millions of people suffering from severe headaches.
Benefits
ATI offers a comprehensive benefits package including:
•Pre-IPO Stock Options
•401(k) Retirement Savings Plan
•Medical (PPO and HSA), Dental and Vision Insurance
•Life insurance
•Long-Term and Short-Term Disability Benefits
•Paid Time Off
•Paid Holidays
•Separate Sick Time Policy
•Snacks and beverages; Lunches provided three times per week
•Company events (we actually have fun!)
ATI is an equal opportunity employer. We are committed to building a workforce that respects individual skills and diversity while embracing teamwork.
